Procter & Gamble Health Ltd.
NSE: PGHL | BSE: 500126
₹6,200.00
₹-1.00
(-0.02%)
As on 05-Jun-2026IST
Market cap
₹10,246 Cr
Revenue (TTM)
₹1,408 Cr
P/E Ratio
31.3
P/B Ratio
19.5
Div. Yield
3.3 %
Quality Score
10/10
Growth Score
3/10
Valuation Score
4/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹327 Cr
-
ROE
44.2 %
-
ROCE
58 %
-
Industry P/E
35.23
-
EV/EBITDA
21.2
-
Debt to Equity
0
-
Book Value
₹316
-
EPS
₹196.9
-
Face value
10
-
Shares outstanding
16,599,382
10 Years Aggregate
CFO
₹1,398.92 Cr
EBITDA
₹2,190.89 Cr
Net Profit
₹1,583.73 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Procter & Gamble Health
| 8.7 | 20.4 | 27.6 | 10.6 | 5.5 | 1.3 | 24.0 |
|
BSE Healthcare
| 8.0 | 3.6 | 8.8 | 9.9 | 24.9 | 13.6 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Procter & Gamble Health
| 9.3 | 5.5 | 25.2 | -26.0 | -23.5 | 54.6 | 38.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Procter & Gamble Health
|
6,200.0 | 10,245.6 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31.3 | 19.5 |
| 2,976.5 | 37,200.8 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 35.2 | 8.2 | |
| 8,600.0 | 21,496.5 | 2,275.6 | 187.5 | 10.3 | 22.9 | 114.6 | 24.6 | |
| 2,033.1 | 15,441.4 | 2,187.2 | 649.7 | 31.5 | 19 | 24.1 | 4.3 | |
| 1,365.2 | 18,859.7 | 3,129.4 | 647.4 | 26.9 | 18.1 | 30.4 | 4.8 | |
| 2,169.3 | 34,833.2 | 4,147.8 | 709.5 | 22.3 | 19.1 | 49.1 | 8.4 | |
| 4,456.3 | 20,381.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.2 | 4.8 | |
| 538.1 | 10,497.9 | 1,538.1 | 226.2 | 20.4 | 9 | 43.1 | 4.1 | |
| 1,044.6 | 9,613.2 | 4,858.7 | 574.1 | 14.9 | 19.7 | 17.3 | 3.1 | |
| 948.0 | 7,632.2 | 827.9 | 209.1 | 32.1 | 18.4 | 36.5 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All News
About Procter & Gamble Health
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its... products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV. Read more
-
Incorporated
1967
-
Chairman
S Madhavan
-
Managing Director
Milind Thatte
-
Group
Merck - MNC
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Procter & Gamble Health Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsRecord Date For Purpose Of Dividend
26-May-2026Corporate Action-Board approves Dividend
26-May-2026Outcome Of The Board Meeting Held On May 26 2026
26-May-2026No News & Announcements are available.
FAQs for Procter & Gamble Health
What is the current share price of Procter & Gamble Health Ltd Today?
The share price of Procter & Gamble Health Ltd is ₹6,200.00 (NSE) and ₹6,172.30 (BSE) as of 05-Jun-2026 IST. Procter & Gamble Health Ltd has given a return of 5.49% in the last 3 years.
What is the current PB & PE ratio of Procter & Gamble Health Ltd?
The P/E ratio of Procter & Gamble Health Ltd is 31.34 times as on 05-Jun-2026, a 11 discount to its peers’ median range of 35.23 times.
The P/B ratio of Procter & Gamble Health Ltd is 19.53 times as on 05-Jun-2026, a 323 premium to its peers’ median range of 4.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
41.71
|
15.83
|
|
2023
|
37.97
|
11.73
|
|
2022
|
36.10
|
11.41
|
|
2021
|
52.52
|
13.27
|
|
2018
|
50.32
|
3.32
|
What is the 52 Week High and Low of Procter & Gamble Health Ltd?
The 52-week high and low of Procter & Gamble Health Ltd are Rs 6,739.00 and Rs 4,707.00 as of 08-Jun-2026.
What is the market cap of Procter & Gamble Health Ltd?
Procter & Gamble Health Ltd has a market capitalisation of ₹ 10,246 Cr as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Procter & Gamble Health Ltd?
Before investing in Procter & Gamble Health Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.